Actinic Purpura

Etiology

Actinic purpura results from skin fragility due to long-term sun exposure, leading to UV-induced dermal atrophy. The dermal connective tissue cannot adequately support the microvasculature, leading to extravasation of blood into the dermis after minor trauma, a finding often neglected in medical history. This is one of the signs of dermatoporosis, which is characterized by skin fragility, skin atrophy, and stellate pseudo-scars.[2][4]

Epidemiology

Actinic purpura is common among older adults, particularly those with fair skin who are more sensitive to sun exposure. The prevalence of actinic purpura increases with age and cumulative UV exposure. The condition is estimated to affect about 12% of individuals older than 50 and 30% of those aged 75 or older; this condition usually affects both sexes equally.[5]

Pathophysiology

Actinic purpura results from extravasation of blood into the dermis. This phenomenon is due to skin atrophy and vascular fragility in older adults, which are exacerbated by chronic sun exposure. The lesions of actinic purpura are commonly located on sun-exposed areas, such as the arms, face, and neck. Skin atrophy in dermatoporosis is due to collagen alteration. These collagen changes may correspond to bone density changes similar to those observed in osteoporosis, suggesting that bone collagen also changes alongside skin collagen, thereby altering bone density. The pronounced skin atrophy caused by photoaging and UV radiation exposure makes the dermal vascular network highly sensitive to even the slightest trauma or shearing force.[6]

The formation of purple patches and macules in actinic purpura results from red blood cell extravasation into the dermis, leading to hemosiderin deposition in the interstitial space. No infiltration of the vessels is observed, and no inflammatory reaction occurs in the dermal tissue. The absence of phagocytosis results in delayed resorption of extravasated blood. This fact results in purple patches and macules of the ecchymotic aspect.[3]

Histopathology

Histopathology of the skin demonstrates epidermal thinning with numerous abnormal keratinocytes arranged in a disorderly pattern. The dermis shows red blood cell extravasation and hemosiderin deposition with no inflammatory cells. The vessel walls of the dermis are normal in structure. Histology of the surrounding skin with solar elastosis showed a blue, homogenized elastotic material present at the base of the epidermis. The amount of collagen in the affected area is markedly decreased.[6][7]

History and Physical

Actinic purpura presents as patches and macules with irregular borders on the forearms and the backs of the hands. However, they can affect other areas, such as the legs, neck, and face. The lesions may appear as dark purple macules and extensive ecchymosis, with average sizes ranging from 1 to 4 cm in diameter.

These macules are asymptomatic and are not associated with pruritus or tenderness. The surrounding skin generally demonstrates altered qualities, appearing thin, pigmented, and inelastic. Besides the typical presentation of actinic purpura, additional signs of photoaging may be evident, including wrinkling, lentigines, a sallow-yellow skin hue, actinic keratoses, and stellate pseudo-scars.[8]

The purpuric lesions persist for about 1 to 3 weeks before resolving spontaneously. However, they do not undergo the phases of inflammation. A residual deposit of hemosiderin in the dermis may leave a brown pigmentation. Actinic purpura can continue to appear due to already established cutaneous and vascular fragility. Although ecchymotic lesions can pose significant aesthetic concerns and psychological effects, they do not carry a risk of serious complications.[3]

Evaluation

The diagnosis of actinic purpura is primarily clinical, based on a detailed patient history and a thorough physical examination, including assessment of lesion distribution on chronically sun-exposed areas, skin quality, and the absence of systemic symptoms. Lesions are painless, noninflammatory, and resolve without scarring within 1 to 3 weeks. Histopathologic evaluation is rarely required but, when performed, demonstrates a thinned epidermis over an atrophic dermis with reduced collagen and abnormal elastic fibers. Dermal vessels maintain normal tensile structure, but red blood cell extravasation and hemosiderin deposition are highlighted by Perl staining. In approximately 10% of cases, neutrophilic infiltration may be observed, mimicking neutrophilic dermatoses or leukocytoclastic vasculitis and potentially leading to misdiagnosis.[9]

Laboratory investigation is generally unnecessary unless atypical features or systemic involvement are suspected. Coagulation studies, complete blood counts, and platelet assessments may be considered when lesions are atypical, widespread, rapidly progressive, or associated with systemic symptoms. Skin biopsy is rarely needed when the diagnosis is uncertain. Histopathology may demonstrate epidermal thinning, dermal atrophy with reduced collagen, solar elastosis, extravasated red blood cells, and hemosiderin deposition, without features of true vasculitis.

Current national and international dermatology guidelines, including those from the American Academy of Dermatology and European Dermatology Forum, recommend a clinical diagnosis without routine laboratory or radiographic evaluation, reserving additional testing for atypical presentations or when alternative diagnoses, such as vasculitis, coagulopathy, or drug-induced purpura, are being considered.[9] Management decisions are guided by the clinical evaluation, emphasizing photoprotection, trauma avoidance, and, when appropriate, topical agents to improve dermal thickness. Clear documentation of lesion appearance, distribution, and patient history supports differentiation from other purpuric disorders and ensures targeted patient education.

Treatment / Management

Actinic purpura is a benign condition that does not require specific treatment, particularly because new lesions continue to develop throughout life. The most effective preventive approach involves protection from excessive sun exposure by applying sunscreen and wearing long-sleeved shirts. Sunscreens with a high protection index (sun protection factor >50) provide sufficient protection against UV-A and UV-B rays and should be applied regularly to all sun-exposed areas.[10][11]

Therapeutic options for actinic purpura lesions that have already formed are limited. Tretinoin or retinoic acid (0.1%) is a vitamin A derivative, which could theoretically reverse UV light–induced severe skin damage. Indeed, topical tretinoin is known for its role in regenerating dermal collagen and reducing the quality of abnormal elastin damaged by solar exposure. However, studies have shown that plaques in actinic purpura do not improve with local tretinoin treatment.[1][3] 

In 2002, actinic purpura was successfully treated in a single patient using tissue-engineered skin; however, no similar cases have been reported. More recently, human epidermal growth factor has shown promise as a potential treatment for actinic purpura. When applied twice daily for 6 weeks, it increased the average skin thickness and reduced the number of purpuric lesions. A citrus bioflavonoid blend has also been tested for the treatment of actinic purpura. After 6 weeks, the treated group showed a 50% decrease in purpuric plaques with no reported adverse effects.

Laser therapy is not indicated for actinic purpura, even though it is commonly used to treat other signs of skin aging.[1] Moisturizing creams may be useful to treat associated skin xerosis.[8] Recent studies have shown that a new intense pulsed light protocol is safe and effective in improving the clinical appearance of actinic purpura and preventing future lesions by enhancing skin structure, increasing epidermal thickness, and improving collagen and elastic fiber morphology. The treatment was well tolerated, adverse effects were minimal, and patient satisfaction was high.[12][13][14](A1)

Differential Diagnosis

The differential diagnosis of actinic purpura includes: 

• Steroid-induced purpura
• Physical trauma
• Drug-induced purpura (eg, anticoagulant therapy)
• Scurvy (vitamin C deficiency) [15]
• Vitamin K deficiency
• Psychogenic purpura
• Palpable purpura associated with hemorrhage and inflammation
• Primary systemic amyloidosis [16]

Prognosis

Actinic purpura has a favorable prognosis and generally follows a benign course. The lesions typically persist throughout life but resolve within 1 to 3 weeks. Resolution may be accompanied by postinflammatory hyperpigmentation due to hemosiderin deposition. Recurrences are common because the underlying dermal and vascular fragility persists. 

Complications

Actinic purpura is a benign condition that typically resolves within 1 to 3 weeks, with residual pigmentation or, in some cases, scarring. Actinic purpura itself is not associated with systemic symptoms. Complications are mainly cosmetic and psychological. The presence of photodamaged, fragile skin may increase the risk of skin tears after minor trauma. These lesions can trigger the patient's emotional distress due to cosmetic disfigurement. Patients may experience distress due to the recurrent patches on the skin.[3]